Sanjivani Paranteral logo

Sanjivani Paranteral

SANJIVANIPARANTERALLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹220 Cr
Volatility
Moderate
P/E Ratio
29.8
EBITDA
₹11.30 Cr
Return on Equity
13.17%
Debt to Equity
0.3
Book Value
₹39.28
EPS
₹5.42
52W High
₹263.95
52W Low
₹126

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

3
  • Promoter holding is low: 31.6%
  • Company might be capitalizing the interest cost
  • Debtor days have increased from 66.8 to 82.0 days.

Growth Rate

Revenue Growth
-2.1% lower than 3Y
Net Income Growth
-17.28% lower than 3Y
Cash Flow Change
-101% lower than 3Y
ROE
-35.12% lower than 3Y
ROCE
-30.9% higher than 3Y
EBITDA Margin (Avg.)
-0.49% lower than 3Y

Quarterly Results

Particulars Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
14.96
12.86
16.44
18.13
17.35
18.18
17.89
15.5
22.06
13.21
23.84
Expenses
12.99
10.7
14.1
15.28
14.8
15.57
15.25
13.25
18.22
11.64
19.67
Operating Profit
1.97
2.16
2.34
2.85
2.55
2.61
2.64
2.25
3.84
1.57
4.17
OPM %
13.17%
16.8%
14.23%
15.72%
14.7%
14.36%
14.76%
14.52%
17.41%
11.88%
17.49%
Other Income
0.25
0.05
0.09
0.39
0.31
0.43
0.04
0.16
0.3
0.6
0.15
Interest
0.08
0.09
0.02
0.18
0.19
0.2
0.22
0.05
0.21
0.31
0.35
Depreciation
0.24
0.24
0.13
0.15
0.16
0.18
0.16
0.17
0.23
0.66
0.65
PBT
1.9
1.88
2.28
2.91
2.51
2.66
2.3
2.19
3.7
1.2
3.32
Tax %
13.16%
33.51%
24.56%
21.31%
24.3%
17.29%
24.78%
25.11%
24.86%
55%
25%
Net Profit
1.65
1.26
1.71
2.3
1.9
2.19
1.73
1.64
2.78
0.55
2.49
EPS in Rs
1.65
1.08
1.46
1.97
1.6
1.84
1.43
1.34
2.26
0.45
2.03
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2024Mar 2025Mar 2026TTM
Sales
54.41
70.1
68.67
74.61
Expenses
46.18
59.76
58.38
62.78
Operating Profit
8.23
10.34
10.29
11.83
OPM %
15.13%
14.75%
14.98%
15.86%
Other Income
0.52
1.22
0.97
1.21
Interest
0.25
0.59
0.65
0.92
Depreciation
0.93
0.62
1.22
1.71
PBT
7.57
10.35
9.39
10.41
Tax %
18.63%
21.84%
28.75%
—
Net Profit
6.17
8.09
6.69
7.46
EPS in Rs
5.28
6.81
5.45
6.08
Div. Payout %
0%
7.34%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2024Mar 2025Mar 2026
Equity Capital
11.68
11.88
12.28
Reserves
16.22
26.11
35.96
Borrowings
0.97
8.14
14.28
Other Liabilities
14.53
32.07
25.46
Total Liabilities
43.4
78.2
87.98
Fixed Assets
9.94
20.64
47.34
CWIP
0
19.11
1.15
Investments
0
0
0.73
Other Assets
33.46
38.45
38.76
Total Assets
43.4
78.2
87.98
Figures in ₹ Crores

Cash Flow

Particulars Mar 2024Mar 2025Mar 2026
Operating
-10.7
12.4
-0.11
Investing
-12.21
-21.91
-9.97
Financing
23.16
10.46
9.84
Net Cash Flow
0.24
0.94
-0.24
Free Cash Flow
-14
-17.95
-10.18
CFO/OP
-117
133
20
Figures in ₹ Crores

Ratios

Particulars Mar 2024Mar 2025Mar 2026
Debtor Days
31.53
86.85
82.01
Inventory Days
125
94.77
91.17
Days Payable
73.56
138
30.61
Cash Conversion Cycle
82.67
44.11
143
Working Capital Days
35.55
-0.1
45.98
ROCE %
—
28.46%
17.96%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sanjivani Paranteral insights

62 extracted metrics + investor summaries across FY10–FY27.

Log in — free

Shareholding Pattern

DIIs5.45%Public49.92%Others13.06%Promot.31.56%As ofJun 2026

Documents

Frequently Asked Questions about Sanjivani Paranteral

What does Sanjivani Paranteral Ltd do?
Incorporated in 1994, Sanjivani Parenteral Ltd is a research-based and export-oriented pharmaceutical company[1]
Where is Sanjivani Paranteral Ltd (531569) listed?
Sanjivani Paranteral Ltd trades as SANJIVANIPARANTERALLTD on the NSE and under code SANJIVIN on the BSE.
Which sector does Sanjivani Paranteral Ltd belong to?
Sanjivani Paranteral Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Sanjivani Paranteral Ltd?
Sanjivani Paranteral Ltd has a market capitalisation of ₹219.93 Cr, which places it in the Small Cap band.
What is the PE ratio of Sanjivani Paranteral Ltd?
Sanjivani Paranteral Ltd trades at a PE ratio of 29.80, on earnings per share of ₹5.42, against a book value of ₹39.28 per share.
What is the 52-week high and low of Sanjivani Paranteral Ltd?
Over the last 52 weeks Sanjivani Paranteral Ltd has traded between ₹126 and ₹263.95.
Does Sanjivani Paranteral Ltd pay dividends?
Sanjivani Paranteral Ltd has a dividend yield of 0.28%.
What is the Return on Equity (ROE) of Sanjivani Paranteral Ltd?
Sanjivani Paranteral Ltd reported a return on equity of 13.17%. Its debt-to-equity ratio is 0.30.

Company Information

Incorporated in 1994, Sanjivani Parenteral Ltd is a research-based and export-oriented pharmaceutical company[1]

Website sanjivani.co.in
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531569.md for Sanjivani Paranteral Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List